Riskpilot← Back to searchSign inGet full accessÖgon Akuten 24 AB
ABActiveOrg 5567525539Virvelvindsgatan 4Medical specialists activities · NACE 8622Est. 20080 employees
Revenue 2024
SEK 3,9M
+20% vs 2023
EBITDA margin
71.7%
+209% vs 2023
Equity ratio
40.1%
Financial strength
Net profit 2024
SEK 1,2M
+920% vs 2023
| Revenue | SEK 3,9M | +20% |
| EBITDA | SEK 2,8M | +209% |
| Net profit | SEK 1,2M | +920% |
| Total assets | SEK 8,9M | +170% |
| Equity | SEK 3,6M | +51% |
| Employees | 0 | — |
Legal name
Ögon Akuten 24 AB
Org number
5567525539
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 februari 2008
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva ögonsjukvård och ögonplastikkirurgi, äga och förvalta andelar, aktier och värdepapper, samt idka därmed förenlig verksamhet.
Address
Virvelvindsgatan 4
Phone
+46735677157
Email
sepherina1957@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 732 | 3 943 | 3 705 | 3 238 | 3 882 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 149 | 1 131 | 646 | 901 | 2 784 |
| Depreciation & amort. | −1 300 | −954 | −9 | −741 | −476 |
| EBIT | −151 | 177 | 637 | 160 | 2 308 |
| Net financials | −22 | −8 | −15 | −11 | −791 |
| Profit before tax | −173 | 168 | 622 | 149 | 1 516 |
| Tax | −0 | −0 | −52 | −31 | −312 |
| Net profit | −173 | 168 | 570 | 118 | 1 204 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 523 | 2 524 | 3 429 | 3 310 | 8 922 |
| Equity | 1 516 | 1 685 | 2 254 | 2 373 | 3 577 |
| Long-term debt | 208 | 0 | 0 | 0 | 2 207 |
| Short-term debt | 1 799 | 839 | 1 175 | 938 | 3 138 |
| Total debt | 2 007 | 839 | 1 175 | 938 | 5 345 |
EBITDA margin
71.7%
This company
15.8%
Market median
+354% vs market
20202024
Equity ratio
40.1%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
33.7%
This company
18.4%
Market median
+83% vs market
20202024
Net profit margin
31.0%
This company
8.1%
Market median
+283% vs market
20202024
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20202024
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PB Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
GL | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ögon Akuten 24 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Bo Weine Karlsson | Chief Auditor | 0 companies |
| Gun-Lis Linnea Bellhem | Audit | 0 companies |
| Media Wullink | Deputy Board Member | 0 companies |
| Ali Reza Ebrahimi | Board of Directors | 0 companies |
| Sven Thomas Kleverman | Deputy Board Member | 0 companies |